980 related articles for article (PubMed ID: 28969667)
1. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
[TBL] [Abstract][Full Text] [Related]
3. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.
Butler CC; Gillespie D; White P; Bates J; Lowe R; Thomas-Jones E; Wootton M; Hood K; Phillips R; Melbye H; Llor C; Cals JWL; Naik G; Kirby N; Gal M; Riga E; Francis NA
N Engl J Med; 2019 Jul; 381(2):111-120. PubMed ID: 31291514
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein-guided antibiotic prescribing for COPD exacerbations: a qualitative evaluation.
Phillips R; Stanton H; Singh-Mehta A; Gillespie D; Bates J; Gal M; Thomas-Jones E; Lowe R; Hood K; Llor C; Melbye H; Cals J; White P; Butler C; Francis N
Br J Gen Pract; 2020 Jul; 70(696):e505-e513. PubMed ID: 32424045
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis.
An X; Zhang C; Weng X; Xiao W; Sun Z; Zeng Z; Huang Q
Medicine (Baltimore); 2020 Jul; 99(29):e21152. PubMed ID: 32702869
[TBL] [Abstract][Full Text] [Related]
6. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
[TBL] [Abstract][Full Text] [Related]
7. Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD.
Gillespie D; Francis N; Ahmed H; Hood K; Llor C; White P; Thomas-Jones E; Stanton H; Sewell B; Phillips R; Naik G; Melbye H; Lowe R; Kirby N; Cochrane A; Bates J; Alam MF; Butler C
Int J Chron Obstruct Pulmon Dis; 2022; 17():383-394. PubMed ID: 35210767
[TBL] [Abstract][Full Text] [Related]
8. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice.
Llor C; Bjerrum L; Munck A; Hansen MP; Córdoba GC; Strandberg EL; Ovhed I; Radzeviciene R; Cots JM; Reutskiy A; Caballero L
Ther Adv Respir Dis; 2013 Jun; 7(3):131-7. PubMed ID: 23325784
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication Skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial.
Ruiz R; Moragas A; Trapero-Bertran M; Sisó A; Berenguera A; Oliva G; Borràs-Santos A; García-Sangenís A; Puig-Junoy J; Cots JM; Morros R; Mora T; Lanau-Roig A; Monfà R; Troncoso A; Abellana RM; Gálvez P; Medina-Perucha L; Bjerrum L; Amo I; Barragán N; Llor C
Trials; 2019 Dec; 20(1):740. PubMed ID: 31847912
[TBL] [Abstract][Full Text] [Related]
10. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial.
Gillespie D; Butler CC; Bates J; Hood K; Melbye H; Phillips R; Stanton H; Alam MF; Cals JW; Cochrane A; Kirby N; Llor C; Lowe R; Naik G; Riga E; Sewell B; Thomas-Jones E; White P; Francis NA
Br J Gen Pract; 2021 Apr; 71(705):e266-e272. PubMed ID: 33657007
[TBL] [Abstract][Full Text] [Related]
11. Effects of primary care C-reactive protein point-of-care testing on antibiotic prescribing by general practice staff: pragmatic randomised controlled trial, England, 2016 and 2017.
Eley CV; Sharma A; Lee H; Charlett A; Owens R; McNulty CAM
Euro Surveill; 2020 Nov; 25(44):. PubMed ID: 33153517
[TBL] [Abstract][Full Text] [Related]
12. An intervention with access to C-reactive protein rapid test reduces antibiotic overprescribing in acute exacerbations of chronic bronchitis and COPD.
Strykowski DF; Nielsen AB; Llor C; Siersma V; Bjerrum L
Fam Pract; 2015 Aug; 32(4):395-400. PubMed ID: 25902912
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial.
Boere TM; El Alili M; van Buul LW; Hopstaken RM; Verheij TJM; Hertogh CMPM; van Tulder MW; Bosmans JE
BMJ Open; 2022 Sep; 12(9):e055234. PubMed ID: 36109036
[TBL] [Abstract][Full Text] [Related]
14. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
[TBL] [Abstract][Full Text] [Related]
15. General Practitioner Antimicrobial Stewardship Programme Study (GAPS): protocol for a cluster randomised controlled trial.
Avent ML; Hansen MP; Gilks C; Del Mar C; Halton K; Sidjabat H; Hall L; Dobson A; Paterson DL; van Driel ML
BMC Fam Pract; 2016 Apr; 17():48. PubMed ID: 27098971
[TBL] [Abstract][Full Text] [Related]
16. Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial.
Boere TM; van Buul LW; Hopstaken RM; van Tulder MW; Twisk JWMR; Verheij TJM; Hertogh CMPM
BMJ; 2021 Sep; 374():n2198. PubMed ID: 34548288
[TBL] [Abstract][Full Text] [Related]
17. Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD).
Rockenschaub P; Jhass A; Freemantle N; Aryee A; Rafiq M; Hayward A; Shallcross L
J Antimicrob Chemother; 2020 Jan; 75(1):243-251. PubMed ID: 31598669
[TBL] [Abstract][Full Text] [Related]
18. Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections.
Schneider JE; Boehme C; Borisch B; Dittrich S
J Med Econ; 2020 Jul; 23(7):673-682. PubMed ID: 32259465
[No Abstract] [Full Text] [Related]
19. The social role of C-reactive protein point-of-care testing to guide antibiotic prescription in Northern Thailand.
Haenssgen MJ; Charoenboon N; Althaus T; Greer RC; Intralawan D; Lubell Y
Soc Sci Med; 2018 Apr; 202():1-12. PubMed ID: 29499522
[TBL] [Abstract][Full Text] [Related]
20. Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care.
Salwan AA; Spigt M; Laue J; Melbye H
BMC Fam Pract; 2015 Mar; 16():40. PubMed ID: 25887285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
